Document is current

Any future updates will be listed below

Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients

Crossref DOI link: https://doi.org/10.1186/1475-2891-14-13

Published Online: 2015-01-26

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark